Body surface marking structure for indicating focus

Abstract

The utility model provides a body surface marking structure for indicating a focus, which relates to the technical field of auxiliary devices of medical detection equipment, and comprises a marking piece body, the marking piece body is provided with an accommodating space, and a filler is arranged in the accommodating space; the marking piece body is provided with a marking part, and the marking part is used for marking the focus position on the skin of a patient. The technical problems that in the prior art, due to the fact that a vitamin E capsule is adopted for marking, the position and range of a focus are not clear, and skin infection is caused in an inpatient area are solved.

Description

Technical Field

[0001] This utility model relates to the technical field of auxiliary devices for medical testing equipment, and in particular to a body surface marking structure for indicating lesions. Background Technology

[0002] During MRI scans, superficial and small lesions are frequently encountered, such as pilosebaceous sinuses in the sacrococcygeal region, fibromas or hemangiomas on the skin surface, and small areas of skin damage. However, because these lesions are small or superficial, radiologists may easily miss them.

[0003] Therefore, to help identify these lesions, doctors often place a vitamin E capsule on the surface of the lesion. The advantage of vitamin E capsules is that they are non-magnetic, do not interfere with MRI scans, and can be visualized on standard MRI sequences, helping radiologists locate lesions. However, while vitamin E capsules can indicate the location of certain lesions, the capsules themselves are relatively large and hard. When placed on the surface of a lesion on the back, they can easily deform the lesion, hindering the visualization of its original morphology.

[0004] Secondly, capsules cannot indicate the size of lesions, only their location. The extent of lesion involvement often plays a crucial role in determining the nature of the disease and choosing the appropriate surgical approach.

[0005] Finally, if the skin in the affected area is already broken, placing the capsule on it can easily cause secondary infection and discomfort to the patient. Placing it on the side of the lesion, however, can lead to misunderstanding because the capsule lacks a directional arrow-like feature. Utility Model Content

[0006] The purpose of this invention is to provide a surface marker structure for indicating lesions, so as to alleviate the technical problems in the prior art that the use of vitamin E capsules for marking causes unclear location and extent of lesions and skin infections in the affected area.

[0007] To achieve the above objectives, the present invention adopts the following technical solution:

[0008] In a first aspect, this utility model provides a body surface marking structure for indicating lesions, wherein the marking body has a receiving space and the receiving space is filled with a filler;

[0009] The marker body is provided with a marking part, which is used to mark the location of lesions on the patient's skin.

[0010] Furthermore, the marker body is provided with a filling end, which is used to connect to an external feeding device for feeding material into the accommodating space.

[0011] Furthermore, the marker body is provided with a connector, the connector is provided with a connecting strap, and the connecting strap is used to fix the marker body to the patient's body.

[0012] Furthermore, the marker body has an adhesive portion on the side opposite to the filling end, and the marker body is used to adhere to the patient's body through the adhesive portion so that the marker portion marks the location of the lesion on the patient's skin.

[0013] Furthermore, the upper surface of the marker body is provided with a scale, which is used to measure the amount of material injected into the accommodating space.

[0014] Furthermore, the marker body has a ring structure, and the center of the ring of the marker body is set as the marking part, which is used to mark the lesions on the patient's skin.

[0015] Furthermore, the marking section comprises ten marking rings connected sequentially from the inside out.

[0016] Furthermore, each of the marked rings has the same side width, and each has a width of 1 cm.

[0017] Furthermore, the marker body has an arrow-shaped structure, and the tip of the marker body is set as the marking part, which is used to indicate the location of lesions on the patient's skin.

[0018] Furthermore, at least two arrow-shaped marker bodies are provided, and the marking portions of the two marker bodies are arranged opposite to each other;

[0019] The spacing between the two opposing markers is used to mark the extent of lesions on the patient's skin.

[0020] This utility model can achieve the following beneficial effects:

[0021] In a first aspect, the present invention provides a body surface marking structure for indicating lesions, including a marking body, the marking body having a receiving space and a filler therein; the marking body having a marking part for marking the location of lesions on the patient's skin.

[0022] In this invention, the marker body has an internal accommodating space, into which a filler is injected during use. The filler must be a non-magnetic material that does not affect magnetic resonance imaging (MRI) examination; preferably, the filler can be an MRI contrast agent. The marking portion of the marker body marks lesions on the patient's skin after being placed on the patient's body, without contaminating or damaging the lesions.

[0023] Compared with the prior art, the surface marking structure for indicating lesions provided by this utility model, by injecting a certain amount of filler into the accommodating space inside the marking body, enables it to determine the location of skin lesions while simultaneously determining the location of lesions on the patient's skin through the marking part of the marking body.

[0024] In summary, this invention at least alleviates the technical problems existing in the prior art, such as unclear location and extent of lesions and skin infections in the affected area caused by the use of vitamin E capsules for marking. Attached Figure Description

[0025] To more clearly illustrate the specific embodiments of this utility model or the technical solutions in the prior art, the drawings used in the description of the specific embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of this utility model. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.

[0026] Figure 1 A schematic diagram of the overall structure of the body surface marking structure for indicating lesions provided in Embodiment 1 of this utility model;

[0027] Figure 2 for Figure 1 Schematic diagram of the AA section structure;

[0028] Figure 3 This is a schematic diagram of the overall structure of the surface marking structure for indicating lesions provided in Embodiment 2 of this utility model.

[0029] Icons: 1-Marker body; 11-Connector; 12-Marker section; 2-Filling end; 3-Connecting belt; 4-Scale. Detailed Implementation

[0030] To make the objectives, technical solutions, and advantages of the embodiments of this utility model clearer, the technical solutions of the embodiments of this utility model will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this utility model, not all embodiments. The components of the embodiments of this utility model described and shown in the accompanying drawings can generally be arranged and designed in various different configurations.

[0031] Therefore, the following detailed description of the embodiments of the present invention provided in the accompanying drawings is not intended to limit the scope of the claimed invention, but merely to illustrate selected embodiments of the invention. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without inventive effort are within the scope of protection of the present invention.

[0032] It should be noted that similar labels and letters in the following figures indicate similar items. Therefore, once an item is defined in one figure, it does not need to be further defined and explained in subsequent figures.

[0033] In the description of this utility model, it should be noted that the terms "upper," "lower," "vertical," "horizontal," "inner," and "outer," etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, or the orientation or positional relationship commonly used when the utility model product is in use. They are only for the convenience of describing this utility model and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on this utility model. In addition, the terms "first," "second," and "third," etc., are only used to distinguish descriptions and should not be construed as indicating or implying relative importance.

[0034] Furthermore, terms such as "horizontal" and "vertical" do not imply that components must be absolutely horizontal or suspended, but rather that they can be slightly tilted. For example, "horizontal" simply means that its direction is more horizontal than "vertical," and does not mean that the structure must be completely horizontal, but can be slightly tilted.

[0035] In the description of this utility model, it should also be noted that, unless otherwise explicitly specified and limited, the terms "set," "install," and "connect" should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral connection; they can refer to a mechanical connection or an electrical connection; they can refer to a direct connection or an indirect connection through an intermediate medium; and they can refer to the internal connection of two components. Those skilled in the art can understand the specific meaning of the above terms in this utility model based on the specific circumstances.

[0036] The following detailed description, in conjunction with the accompanying drawings, outlines some embodiments of the present invention. Unless otherwise specified, the following embodiments and features can be combined with each other.

[0037] Example 1

[0038] This embodiment provides a surface marker structure for indicating lesions, referring to... Figure 1 or Figure 2 The surface marking structure for indicating lesions includes a marker body 1, which has a receiving space and a filler inside the receiving space; the marker body 1 has a marking part 12, which is used to mark the location of lesions on the patient's skin.

[0039] This invention at least alleviates the technical problems existing in the prior art, such as unclear location and extent of lesions and skin infections in the affected area caused by the use of vitamin E capsules for marking.

[0040] In this embodiment of the invention, the marker body 1 has an internal accommodating space, and a filler is injected into this accommodating space during use. The filler needs to be a non-magnetic material that does not affect the magnetic resonance examination; and preferably, the filler can be a magnetic resonance contrast agent. The marking part of the marker body 1 is used to mark lesions on the patient's skin after being placed on the patient's body, without causing contamination or damage to the lesions.

[0041] Compared with the prior art, the surface marking structure for indicating lesions provided in this embodiment of the utility model, by injecting a certain amount of filler into the accommodating space in the marker body, enables it to determine the location of skin lesions while simultaneously determining the location of lesions on the patient's skin through the marking part of the marker body 1.

[0042] In an optional implementation of this embodiment, refer to Figure 1 or Figure 2 The marker body 1 is provided with a filling end 2, which is used to connect to an external feeding device for feeding material into the accommodating space.

[0043] Specifically, the filling end 2 is preferably connected to the upper surface of the marking body 1, and the filling end 2 communicates with the accommodating space. In use, one end of the filling end 2 is connected to an external feeding device, and the filling material is injected into the accommodating space from the filling end 2 through the external feeding device. After use, the filling material can be removed from the filling end 2 using an extraction device. It should be noted that the filling end 2 is equipped with a sealing element to seal the opening after filling.

[0044] Furthermore, referring to Figure 1 The marker body 1 is provided with a connector 11, and the connector 11 is provided with a connecting strap 3, which is used to fix the marker body 1 to the patient's body.

[0045] Specifically: the marker body 1 is provided with a connector 11, and the connector 11 can be a ring structure, and is connected to the connecting strip 3 through the ring structure; preferably, there are two connecting strips 3, and the free ends of the two connecting strips 3 are detachably connected for connection to the limbs and other parts of the human body.

[0046] In an optional implementation of this embodiment, refer to Figure 1 or Figure 2 The marker body 1 has an adhesive part on the side opposite to the filling end 2. The marker body 1 is used to adhere to the patient's body through the adhesive part so that the marker part 12 marks the location of the lesion on the patient's skin.

[0047] Specifically: The side of the marker body 1 facing away from the filling end 2 is provided with an adhesive part, and the adhesive part can be evenly distributed on the bottom surface of the marker body 1 so that when in use, the marker body 1 can be positioned relative to the patient's skin lesion by adhering the adhesive part to the patient's skin.

[0048] In an optional implementation of this embodiment, refer to Figure 1 The upper surface of the marker body 1 is provided with a scale 4, which is used to measure the amount of material injected into the accommodating space.

[0049] Specifically: The upper surface of the marker body 1 is provided with a scale 4. Before inserting the marker body 1 into the interior, the marker body 1 is placed horizontally, and then filler material is injected into the accommodating space inside the marker body 1. The amount of filler material injected is then determined according to the scale of the scale 4.

[0050] In an optional implementation of this embodiment, refer to Figure 1 The marker body 1 has a ring structure, and the center of the ring of the marker body 1 is set as the marking part 12, which is used to mark the lesions on the patient's skin.

[0051] Specifically: the marker body 1 is a ring structure, and the center of the ring is set as the marking part 12. That is, the center of the ring structure marker body 1 is used to circle the lesion on the patient's skin to achieve the marking function.

[0052] Furthermore, referring to Figure 1 The marking part 12 consists of ten marking rings connected in sequence from the inside to the outside.

[0053] Specifically: the marking part 12 comprises ten marking rings connected sequentially from the inside to the outside; preferably, the marking rings are composed of ten rings with inner diameters of 1cm, 2cm, 3cm, 4cm, 5cm, 6cm, 7cm, 8cm, 9cm and 10cm respectively.

[0054] Furthermore, each marking ring has the same side width, and each ring is 1cm wide.

[0055] Specifically: the marking rings have equal side widths, and each is 1cm wide; preferably, the marking rings are made of an elastic plastic-sealed magnetic resonance contrast agent.

[0056] Example 2

[0057] This embodiment provides a surface marker structure for indicating lesions, referring to... Figure 3 The marker body 1 has an arrow-shaped structure, and the tip of the marker body 1 is set as a marking part 12, which is used to indicate the location of the lesion on the patient's skin.

[0058] Specifically: the marker body 1 has an arrow-shaped structure, and a receiving space is provided within the marker body 1 for injecting filler material into the interior of the marker body 1 through the filling end 2. The arrow-shaped marker body 1 is the marking part 12, used to point to the location of lesions on the patient's skin. It should be noted that the arrow-shaped marker body 1 is 2cm long and 1cm wide, and is made of magnetic resonance contrast agent sealed with elastic plastic. It can be connected to the patient's body via a connecting strap 3 or by providing an adhesive part.

[0059] Furthermore, referring to Figure 2 At least two arrow-shaped marker bodies 1 are provided, and the marking portions 12 of the two marker bodies 1 are arranged opposite to each other; the distance between the two oppositely arranged marking portions 12 is used to mark the extent of the lesion on the patient's skin.

[0060] Specifically: There are at least two arrow-shaped marker bodies 1, and the two marker bodies 1 can be arranged opposite each other, that is, the marking parts 12 of the two marker bodies 1 are distributed opposite each other, and the two are placed at both ends of the lesion respectively. Therefore, the distance between the two marking parts 12 can be directly regarded as the lesion range on the skin surface.

[0061] Finally, it should be noted that the various embodiments in this specification are described in a progressive manner, with each embodiment focusing on the differences from other embodiments. Similar or identical parts between embodiments can be referred to mutually. The above embodiments in this specification are only used to illustrate the technical solutions of this utility model, and not to limit it. Although this utility model has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some or all of the technical features. These modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the various embodiments of this utility model.

Claims

1. A surface marker structure for indicating lesions, characterized in that, Includes a marker body (1), the marker body (1) having a receiving space, and the receiving space having a filler; The marker body (1) is provided with a marking part (12), which is used to mark the location of lesions on the patient's skin; The marker body (1) is provided with a filling end (2), which is used to connect to an external feeding device for feeding material into the accommodating space; The marker body (1) is provided with a connector (11), the connector (11) is provided with a connecting strap (3), the connecting strap (3) is used to fix the marker body (1) to the patient's body.

2. The body surface marker structure for indicating lesions according to claim 1, characterized in that, The marker body (1) has an adhesive part on the side opposite to the filling end (2). The marker body (1) is used to be attached to the patient's body through the adhesive part so that the marker part (12) marks the location of the lesion on the patient's skin.

3. The body surface marker structure for indicating lesions according to claim 1, characterized in that, The upper surface of the marker body (1) is provided with a scale (4), which is used to measure the amount of material injected into the accommodating space.

4. The body surface marker structure for indicating lesions according to any one of claims 1-3, characterized in that, The marker body (1) has a ring structure, and the marker part (12) is set at the center of the ring of the marker body (1). The marker part (12) is used to mark the lesions on the patient's skin.

5. The body surface marker structure for indicating lesions according to claim 4, characterized in that, The marking section (12) consists of ten marking rings connected in sequence from the inside to the outside.

6. The body surface marker structure for indicating lesions according to claim 5, characterized in that, Each of the marked rings has the same side width, and each ring is 1 cm wide.

7. The body surface marker structure for indicating lesions according to any one of claims 1-3, characterized in that, The marker body (1) has an arrow-shaped structure, and the tip of the marker body (1) is set as the marker part (12), which is used to indicate the location of the lesion on the patient's skin.

8. The body surface marker structure for indicating lesions according to claim 7, characterized in that, At least two arrow-shaped marker bodies (1) are provided, and the marker portions (12) of the two marker bodies (1) are arranged opposite to each other; The spacing between the two opposing markers (12) is used to mark the extent of lesions on the patient's skin.

Images